FDA Recall: HeartStart MRx Monitor/Defibrillator

February 24, 2017

Phillips is recalling the HeartStart MRx Monitor/Defibrillator due to electrical and battery connection issues that may prevent the device from powering up, charging, and delivering an electrical shock therapy. The device may also unexpectedly stop pacing. A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury, or death. 

View the complete FDA information on this recall.